Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
María Josefa
Pajares Villandiego
Publications by the researcher in collaboration with María Josefa Pajares Villandiego (60)
2022
-
Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice
Nutrients, Vol. 14, Núm. 3
2021
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337
2020
-
Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion
Journal of Cell Biology, Vol. 219, Núm. 9
2019
-
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Thorax, Vol. 74, Núm. 4, pp. 371-379
-
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
Scientific Reports, Vol. 9, Núm. 1
-
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Lung Cancer, Vol. 135, pp. 151-160
-
Tmprss4: A novel tumor prognostic indicator for the stratification of stage ia tumors and a liquid biopsy biomarker for nsclc patients
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects
American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 9, pp. 1164-1176
-
Complement C4d-specific antibodies for the diagnosis of lung cancer
Oncotarget, Vol. 9, Núm. 5, pp. 6346-6355
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer
Laboratory Investigation, Vol. 98, Núm. 12, pp. 1562-1574
2017
-
A combined PD-1/C5a blockade synergistically protects against lung cancer growth and metastasis
Cancer Discovery, Vol. 7, Núm. 7, pp. 694-703
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
-
Telomere length, COPD and emphysema as risk factors for lung cancer
European Respiratory Journal
2016
-
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer
Molecular Oncology, Vol. 10, Núm. 9, pp. 1437-1449
-
A novel epigenetic signature for early diagnosis in lung cancer
Clinical Cancer Research, Vol. 22, Núm. 13, pp. 3361-3371
-
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
Oncotarget, Vol. 7, Núm. 16, pp. 22752-22769